Bio-Rad Laboratories, Inc. (BIO)
USD 236.34
(-1.7%)
USD 236.34
(-1.7%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.55 Billion USD | -8.45% |
| 2022 | 3.88 Billion USD | -5.41% |
| 2021 | 4.1 Billion USD | 32.85% |
| 2020 | 3.09 Billion USD | 37.22% |
| 2019 | 2.25 Billion USD | 41.94% |
| 2018 | 1.58 Billion USD | 18.35% |
| 2017 | 1.34 Billion USD | 6.17% |
| 2016 | 1.26 Billion USD | 3.5% |
| 2015 | 1.22 Billion USD | 5.61% |
| 2014 | 1.15 Billion USD | -3.82% |
| 2013 | 1.2 Billion USD | -15.04% |
| 2012 | 1.41 Billion USD | 4.62% |
| 2011 | 1.35 Billion USD | -11.16% |
| 2010 | 1.52 Billion USD | 21.14% |
| 2009 | 1.25 Billion USD | 30.0% |
| 2008 | 966.62 Million USD | 0.12% |
| 2007 | 965.47 Million USD | 24.32% |
| 2006 | 776.63 Million USD | 1.04% |
| 2005 | 768.6 Million USD | -3.33% |
| 2004 | 795.11 Million USD | 61.92% |
| 2003 | 491.05 Million USD | 45.45% |
| 2002 | 337.61 Million USD | -15.63% |
| 2001 | 400.15 Million USD | -0.38% |
| 2000 | 401.66 Million USD | -10.5% |
| 1999 | 448.8 Million USD | 193.33% |
| 1998 | 153 Million USD | -1.42% |
| 1997 | 155.2 Million USD | 53.06% |
| 1996 | 101.4 Million USD | -20.78% |
| 1995 | 128 Million USD | -4.41% |
| 1994 | 133.9 Million USD | -10.49% |
| 1993 | 149.6 Million USD | -9.66% |
| 1992 | 165.6 Million USD | 2.03% |
| 1991 | 162.3 Million USD | 22.86% |
| 1990 | 132.1 Million USD | 14.37% |
| 1989 | 115.5 Million USD | 20.56% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.9 Billion USD | -18.24% |
| 2024 Q3 | 3.11 Billion USD | 7.08% |
| 2024 Q1 | 3.55 Billion USD | 0.02% |
| 2023 Q1 | 3.9 Billion USD | 0.44% |
| 2023 Q4 | 3.55 Billion USD | 2.25% |
| 2023 FY | 3.55 Billion USD | -8.45% |
| 2023 Q3 | 3.47 Billion USD | -1.46% |
| 2023 Q2 | 3.53 Billion USD | -9.54% |
| 2022 Q4 | 3.88 Billion USD | 7.81% |
| 2022 Q3 | 3.6 Billion USD | -4.11% |
| 2022 Q2 | 3.75 Billion USD | -10.29% |
| 2022 Q1 | 4.19 Billion USD | 2.0% |
| 2022 FY | 3.88 Billion USD | -5.41% |
| 2021 Q4 | 4.1 Billion USD | -11.09% |
| 2021 FY | 4.1 Billion USD | 32.85% |
| 2021 Q3 | 4.62 Billion USD | 31.18% |
| 2021 Q2 | 3.52 Billion USD | 5.97% |
| 2021 Q1 | 3.32 Billion USD | 7.48% |
| 2020 FY | 3.09 Billion USD | 37.22% |
| 2020 Q1 | 2.39 Billion USD | 6.1% |
| 2020 Q2 | 2.74 Billion USD | 14.75% |
| 2020 Q3 | 3.19 Billion USD | 16.47% |
| 2020 Q4 | 3.09 Billion USD | -3.23% |
| 2019 Q3 | 2.04 Billion USD | -5.29% |
| 2019 Q4 | 2.25 Billion USD | 10.16% |
| 2019 Q2 | 2.16 Billion USD | 8.06% |
| 2019 FY | 2.25 Billion USD | 41.94% |
| 2019 Q1 | 1.99 Billion USD | 25.9% |
| 2018 FY | 1.58 Billion USD | 18.35% |
| 2018 Q4 | 1.58 Billion USD | -12.67% |
| 2018 Q3 | 1.81 Billion USD | 4.06% |
| 2018 Q2 | 1.74 Billion USD | 1.18% |
| 2018 Q1 | 1.72 Billion USD | 28.71% |
| 2017 FY | 1.34 Billion USD | 6.17% |
| 2017 Q4 | 1.34 Billion USD | 0.33% |
| 2017 Q3 | 1.33 Billion USD | 0.36% |
| 2017 Q2 | 1.33 Billion USD | 7.0% |
| 2017 Q1 | 1.24 Billion USD | -1.46% |
| 2016 FY | 1.26 Billion USD | 3.5% |
| 2016 Q3 | 1.31 Billion USD | 4.52% |
| 2016 Q4 | 1.26 Billion USD | -4.05% |
| 2016 Q2 | 1.26 Billion USD | 4.23% |
| 2016 Q1 | 1.2 Billion USD | -0.99% |
| 2015 Q2 | 1.16 Billion USD | 3.44% |
| 2015 Q3 | 1.23 Billion USD | 6.02% |
| 2015 FY | 1.22 Billion USD | 5.61% |
| 2015 Q1 | 1.12 Billion USD | -2.46% |
| 2015 Q4 | 1.22 Billion USD | -1.26% |
| 2014 Q1 | 1.2 Billion USD | 0.56% |
| 2014 Q3 | 1.2 Billion USD | -0.7% |
| 2014 Q2 | 1.21 Billion USD | 0.75% |
| 2014 FY | 1.15 Billion USD | -3.82% |
| 2014 Q4 | 1.15 Billion USD | -4.4% |
| 2013 Q2 | 1.41 Billion USD | -0.96% |
| 2013 Q4 | 1.2 Billion USD | 3.97% |
| 2013 Q3 | 1.15 Billion USD | -18.11% |
| 2013 Q1 | 1.42 Billion USD | 0.76% |
| 2013 FY | 1.2 Billion USD | -15.04% |
| 2012 FY | 1.41 Billion USD | 4.62% |
| 2012 Q1 | 1.34 Billion USD | -0.34% |
| 2012 Q2 | 1.31 Billion USD | -2.33% |
| 2012 Q3 | 1.36 Billion USD | 3.88% |
| 2012 Q4 | 1.41 Billion USD | 3.46% |
| 2011 Q1 | 1.29 Billion USD | -14.91% |
| 2011 Q2 | 1.31 Billion USD | 1.78% |
| 2011 Q3 | 1.27 Billion USD | -3.2% |
| 2011 Q4 | 1.35 Billion USD | 5.98% |
| 2011 FY | 1.35 Billion USD | -11.16% |
| 2010 Q1 | 1.24 Billion USD | -0.85% |
| 2010 FY | 1.52 Billion USD | 21.14% |
| 2010 Q4 | 1.52 Billion USD | 21.38% |
| 2010 Q3 | 1.25 Billion USD | 2.42% |
| 2010 Q2 | 1.22 Billion USD | -1.73% |
| 2009 Q2 | 1.21 Billion USD | 35.65% |
| 2009 FY | 1.25 Billion USD | 30.0% |
| 2009 Q1 | 897 Million USD | -9.99% |
| 2009 Q4 | 1.25 Billion USD | 0.49% |
| 2009 Q3 | 1.25 Billion USD | 2.77% |
| 2008 Q4 | 996.53 Million USD | 7.25% |
| 2008 Q2 | 952.18 Million USD | 1.21% |
| 2008 Q1 | 940.77 Million USD | -2.56% |
| 2008 FY | 966.62 Million USD | 0.12% |
| 2008 Q3 | 929.12 Million USD | -2.42% |
| 2007 Q3 | 766.14 Million USD | 1.08% |
| 2007 Q4 | 965.47 Million USD | 26.02% |
| 2007 Q1 | 746.37 Million USD | -3.9% |
| 2007 FY | 965.47 Million USD | 24.32% |
| 2007 Q2 | 757.94 Million USD | 1.55% |
| 2006 Q1 | 712.13 Million USD | -7.35% |
| 2006 FY | 776.63 Million USD | 1.04% |
| 2006 Q2 | 737.92 Million USD | 3.62% |
| 2006 Q3 | 738.89 Million USD | 0.13% |
| 2006 Q4 | 776.63 Million USD | 5.11% |
| 2005 Q2 | 763.93 Million USD | -1.38% |
| 2005 Q3 | 777.03 Million USD | 1.72% |
| 2005 Q4 | 768.6 Million USD | -1.08% |
| 2005 FY | 768.6 Million USD | -3.33% |
| 2005 Q1 | 774.62 Million USD | -2.58% |
| 2004 Q2 | 478.24 Million USD | -0.21% |
| 2004 Q4 | 795.11 Million USD | 47.64% |
| 2004 FY | 795.11 Million USD | 61.92% |
| 2004 Q1 | 479.24 Million USD | -2.41% |
| 2004 Q3 | 538.53 Million USD | 12.61% |
| 2003 Q3 | 466.34 Million USD | 42.71% |
| 2003 FY | 491.05 Million USD | 45.45% |
| 2003 Q1 | 325.39 Million USD | -3.62% |
| 2003 Q2 | 326.77 Million USD | 0.43% |
| 2003 Q4 | 491.05 Million USD | 5.3% |
| 2002 FY | 337.61 Million USD | -15.63% |
| 2002 Q3 | 362.49 Million USD | -0.2% |
| 2002 Q4 | 337.61 Million USD | -6.86% |
| 2002 Q1 | 381.82 Million USD | -4.58% |
| 2002 Q2 | 363.21 Million USD | -4.87% |
| 2001 FY | 400.15 Million USD | -0.38% |
| 2001 Q4 | 400.15 Million USD | -2.92% |
| 2001 Q3 | 412.18 Million USD | 1.94% |
| 2001 Q2 | 404.31 Million USD | 0.17% |
| 2001 Q1 | 403.61 Million USD | 0.49% |
| 2000 Q3 | 405.46 Million USD | -8.41% |
| 2000 Q4 | 401.66 Million USD | -0.94% |
| 2000 FY | 401.66 Million USD | -10.5% |
| 2000 Q1 | 452.36 Million USD | 0.79% |
| 2000 Q2 | 442.69 Million USD | -2.14% |
| 1999 Q1 | 148.7 Million USD | -2.81% |
| 1999 Q3 | 141.9 Million USD | -0.42% |
| 1999 Q4 | 448.8 Million USD | 216.28% |
| 1999 Q2 | 142.5 Million USD | -4.17% |
| 1999 FY | 448.8 Million USD | 193.33% |
| 1998 Q2 | 160 Million USD | -1.36% |
| 1998 Q4 | 153 Million USD | 2.27% |
| 1998 FY | 153 Million USD | -1.42% |
| 1998 Q1 | 162.2 Million USD | 4.51% |
| 1998 Q3 | 149.6 Million USD | -6.5% |
| 1997 Q4 | 155.2 Million USD | 47.67% |
| 1997 Q1 | 104.1 Million USD | 2.66% |
| 1997 Q2 | 97.7 Million USD | -6.15% |
| 1997 Q3 | 105.1 Million USD | 7.57% |
| 1997 FY | 155.2 Million USD | 53.06% |
| 1996 Q1 | 125.2 Million USD | -2.19% |
| 1996 Q2 | 116.8 Million USD | -6.71% |
| 1996 Q3 | 109.8 Million USD | -5.99% |
| 1996 Q4 | 101.4 Million USD | -7.65% |
| 1996 FY | 101.4 Million USD | -20.78% |
| 1995 FY | 128 Million USD | -4.41% |
| 1995 Q1 | 144.2 Million USD | 7.69% |
| 1995 Q2 | 138.7 Million USD | -3.81% |
| 1995 Q3 | 130.4 Million USD | -5.98% |
| 1995 Q4 | 128 Million USD | -1.84% |
| 1994 Q2 | 144.9 Million USD | -2.56% |
| 1994 Q4 | 133.9 Million USD | -3.18% |
| 1994 FY | 133.9 Million USD | -10.49% |
| 1994 Q1 | 148.7 Million USD | -0.6% |
| 1994 Q3 | 138.3 Million USD | -4.55% |
| 1993 Q1 | 170.1 Million USD | 2.72% |
| 1993 Q2 | 172.5 Million USD | 1.41% |
| 1993 Q3 | 162.6 Million USD | -5.74% |
| 1993 Q4 | 149.6 Million USD | -8.0% |
| 1993 FY | 149.6 Million USD | -9.66% |
| 1992 Q4 | 165.6 Million USD | -0.66% |
| 1992 FY | 165.6 Million USD | 2.03% |
| 1992 Q1 | 164.6 Million USD | 1.42% |
| 1992 Q2 | 190.6 Million USD | 15.8% |
| 1992 Q3 | 166.7 Million USD | -12.54% |
| 1991 Q4 | 162.3 Million USD | 7.84% |
| 1991 Q1 | 137 Million USD | 3.71% |
| 1991 Q2 | 139.3 Million USD | 1.68% |
| 1991 Q3 | 150.5 Million USD | 8.04% |
| 1991 FY | 162.3 Million USD | 22.86% |
| 1990 FY | 132.1 Million USD | 14.37% |
| 1990 Q2 | 120.4 Million USD | 2.64% |
| 1990 Q3 | 123.5 Million USD | 2.57% |
| 1990 Q4 | 132.1 Million USD | 6.96% |
| 1990 Q1 | 117.3 Million USD | 1.56% |
| 1989 FY | 115.5 Million USD | 20.56% |
| 1989 Q4 | 115.5 Million USD | 5.58% |
| 1989 Q3 | 109.4 Million USD | 1.48% |
| 1989 Q2 | 107.8 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Abbott Laboratories | 34.38 Billion USD | 89.653% |
| Allurion Technologies Inc. | 142.19 Million USD | -2402.083% |
| Artivion, Inc. | 510.61 Million USD | -596.792% |
| Avanos Medical, Inc. | 456.1 Million USD | -680.078% |
| Butterfly Network, Inc. | 84.22 Million USD | -4124.525% |
| Butterfly Network, Inc. | 84.22 Million USD | -4124.525% |
| Boston Scientific Corporation | 15.6 Billion USD | 77.201% |
| CONMED Corporation | 1.46 Billion USD | -142.73% |
| Edwards Lifesciences Corporation | 2.64 Billion USD | -34.577% |
| Paragon 28, Inc. | 162.95 Million USD | -2083.346% |
| Glaukos Corporation | 478.64 Million USD | -643.331% |
| Globus Medical, Inc. | 1.08 Billion USD | -226.979% |
| Inspire Medical Systems, Inc. | 104.29 Million USD | -3311.351% |
| Integer Holdings Corporation | 1.41 Billion USD | -151.76% |
| Medtronic plc | 39.56 Billion USD | 91.006% |
| Myomo, Inc. | 5.59 Million USD | -63523.003% |
| Nevro Corp. | 330.31 Million USD | -977.148% |
| Owlet, Inc. | 73.79 Million USD | -4721.118% |
| Penumbra, Inc. | 377.36 Million USD | -842.847% |
| Vicarious Surgical Inc. | 21.89 Million USD | -16149.998% |
| Smith & Nephew plc | 4.77 Billion USD | 25.41% |
| STERIS plc | 4.74 Billion USD | 25.07% |
| Stryker Corporation | 21.31 Billion USD | 83.311% |
| Vapotherm, Inc. | 132.95 Million USD | -2576.127% |
| Zimmer Biomet Holdings, Inc. | 9 Billion USD | 60.506% |